153 related articles for article (PubMed ID: 3980561)
1. Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.
Umbach GE; Hug V; Spitzer G; Tomasovic B; Thames H; Ajani JA; Drewinko B
J Cancer Res Clin Oncol; 1985; 109(2):130-4. PubMed ID: 3980561
[TBL] [Abstract][Full Text] [Related]
2. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
[TBL] [Abstract][Full Text] [Related]
3. Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptinium.
Umbach GE; Hug V; Spitzer G; Thames H; Drewinko B
Invest New Drugs; 1984; 2(3):263-5. PubMed ID: 6210262
[TBL] [Abstract][Full Text] [Related]
4. Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.
Umbach GE; Singletary SE; Tomasovic B; Spitzer G; Hug V; Drewinko B
Int J Cell Cloning; 1984 Nov; 2(6):335-40. PubMed ID: 6542929
[TBL] [Abstract][Full Text] [Related]
5. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
Hug V; Thames H; Blumenschein GR; Spitzer G; Drewinko B
Cancer Res; 1984 Mar; 44(3):923-8. PubMed ID: 6692414
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of myeloid progenitor cells in healthy subjects and patients with chronic myeloid leukemia to chemotherapeutic agents.
Spiro TE; Mattelaer MA; Efira A; Stryckmans P
J Natl Cancer Inst; 1981 Jun; 66(6):1053-9. PubMed ID: 6941040
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity patterns of standard and investigational agents on human bone marrow granulocyte-macrophage progenitor cells.
Ajani JA; Spitzer G; Tomasovic B; Drewinko B; Hug VM; Dicke K
Br J Cancer; 1986 Oct; 54(4):607-13. PubMed ID: 3778805
[TBL] [Abstract][Full Text] [Related]
10. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
Young JW; Szabolcs P; Moore MA
J Exp Med; 1995 Oct; 182(4):1111-9. PubMed ID: 7561684
[TBL] [Abstract][Full Text] [Related]
11. In vivo acute hematotoxicity of N,N'-bis[N-(2-chloroethyl)-N-nitrosocarbamoyl]cystamine (CNCC), a new nitrosourea analog.
Blazsek I; Mathé G; Maral R; Jasmin C
Toxicol Appl Pharmacol; 1984 Jun; 74(2):250-7. PubMed ID: 6740675
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effect of dose and schedule on normal murine hematopoietic progenitor cells following the administration of 4'-deoxydoxorubicin.
Pannacciulli I; Muzzulini C; Massa G; Bogliolo G
Br J Cancer; 1984 Nov; 50(5):647-56. PubMed ID: 6498062
[TBL] [Abstract][Full Text] [Related]
13. Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.
Fiebig HH; Schmid JR; Bieser W; Henss H; Lohr GW
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):937-48. PubMed ID: 3665999
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of dimethylaminosulfonates of alkane diols as a novel group of anticancer agents.
Sanyal U; Nanda R; Samanta S; Pain A; Dutta S; Verma AS; Rider BJ; Agrawal KC
Cancer Lett; 2000 Jul; 155(1):89-97. PubMed ID: 10814884
[TBL] [Abstract][Full Text] [Related]
15. Correlation of hematologic toxicity of antineoplastic agents with their effects on bone marrow stem cells: interspecies studies using an in vivo assay.
Marsh JC
Exp Hematol; 1985; 13 Suppl 16():16-22. PubMed ID: 3987835
[TBL] [Abstract][Full Text] [Related]
16. [Effect of imidazole antifungal agents on colony formation by murine bone marrow CFUc (colony forming units in culture].
Benkó I; Megyeri A; Hernádi F; Kovács P
Acta Pharm Hung; 1996 Nov; 66(6):241-5. PubMed ID: 9604489
[TBL] [Abstract][Full Text] [Related]
17. Resistance of human bone marrow CFUC to high-dose methotrexate cytotoxicity.
Koizumi S; Yamagami M; Ueno Y; Miura M; Taniguchi N
Exp Hematol; 1980 May; 8(5):635-40. PubMed ID: 7461061
[TBL] [Abstract][Full Text] [Related]
18. [Stem cell factor (SCF) supports granulocyte progenitor survival in mouse bone marrow cultures].
Cáceres-Cortés JR; Santiago-Osorio E; Monroy-García A; Mora-García L; Weiss-Steider B
Rev Invest Clin; 1999; 51(2):107-16. PubMed ID: 10410590
[TBL] [Abstract][Full Text] [Related]
19. Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells.
Clemons M; Watson A; Howell A; Chang J; Heyworth C; Lord B; Testa N; Dexter TM; Margison G
Clin Cancer Res; 2000 Mar; 6(3):966-70. PubMed ID: 10741722
[TBL] [Abstract][Full Text] [Related]
20. Effect of cytokines on the toxicity of cytostatic drugs to normal bone marrow cells in vitro.
Sundman-Engberg B; Paul C; Tidefelt U
Cancer Chemother Pharmacol; 1998; 42(3):255-60. PubMed ID: 9685063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
